Drug Discovery · Jersey City, NJ · Founded 2018 · Privately Held (backing)
Developer of a topical formulation technology designed to treat orphan ophthalmic disorders. Claris Bio is based in Jersey City, NJ and was founded in 2018. It was valued at $163 million at its later-stage round in Nov 2025, the last priced event on record. It has raised $154 million across 1 recorded round; the latest was a $54.5 million Series A in Jan 2024.
These 5 firms already write checks for companies like Claris Bio in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.